1. Home
  2. FF vs RANI Comparison

FF vs RANI Comparison

Compare FF & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$3.41

Market Cap

141.5M

Sector

Industrials

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.35

Market Cap

134.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
RANI
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
134.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FF
RANI
Price
$3.41
$1.35
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.67
AVG Volume (30 Days)
208.2K
2.7M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
7.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$137,409,000.00
$1,200,000.00
Revenue This Year
N/A
$414.59
Revenue Next Year
N/A
$30.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$0.39
52 Week High
$5.78
$3.87

Technical Indicators

Market Signals
Indicator
FF
RANI
Relative Strength Index (RSI) 50.22 40.73
Support Level $3.15 $1.52
Resistance Level $3.49 $1.67
Average True Range (ATR) 0.11 0.13
MACD 0.04 -0.04
Stochastic Oscillator 77.92 3.04

Price Performance

Historical Comparison
FF
RANI

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: